跳至主要内容
临床试验/IRCT20240128060828N1
IRCT20240128060828N1招募中1 期

Evaluation of the safety and efficacy of the injection of placenta-derived mesenchymal stromal/stem cell exosomes with and without priming with TNF-a in patients with complex perianal fistula without a history of CHRONS disease: A double-blinded randomized controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • sign the informed consent
  • Patients with complex perianal fistula aged 18-75
  • Acceptable general health of patients based on physical tests and medical history (absence of diseases or disorders that may interfere with the treatment method evaluated in this study)

排除标准

  • Patients with underlying diseases that affect the pathophysiology of perianal fistula (including IBD, rectovaginal fistula or acute sepsis, uncontrolled diabetes, and active or latent HIV, HBV, or HCV infection)
  • Patients who need perianal surgery for reasons other than fistula
  • Major surgeries within 28 days before admission
  • Use of immune system modulators for reasons other than fistula in patients

研究者

相似试验